MiR‐5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6

Publisher: John Wiley & Sons Inc

E-ISSN: 1098-2744|57|3|419-428

ISSN: 0899-1987

Source: Molecular Carcinogenesis, Vol.57, Iss.3, 2018-03, pp. : 419-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract